Literature DB >> 25431194

Intestinal metaplasia of the sinonasal mucosa adjacent to intestinal-type adenocarcinoma. A morphologic, immunohistochemical, and molecular study.

Alessandro Franchi1, Annarita Palomba, Lucia Miligi, Valentina Ranucci, Duccio Rossi Degli Innocenti, Antonella Simoni, Monica Pepi, Marco Santucci.   

Abstract

It has been hypothesized that the development of sinonasal intestinal-type adenocarcinoma (ITAC) occurs through intestinal metaplasia (IM) of the respiratory and/or glandular epithelium. The aim of this study was to characterize the histological, immunohistochemical, and molecular features of sinonasal IM. Histologic slides from 29 consecutive surgical specimens of ITAC were retrieved. Sections were stained for CDX2, cytokeratin 20 (CK20), MUC2, and p53. The status of TP53 gene exons 4-9 was assessed separately in areas of IM and in ITAC. Foci of IM were detected in eight cases (27.5%). They were all positive for CK20 and CDX2, while MUC2 was detected in six cases (75%). In six cases (75%), the metaplastic foci showed signs of dysplasia, including nuclear enlargement with increased nucleus to cytoplasm ratio, nuclear hyperchromasia, loss of nuclear polarity, and presence of prominent nucleoli. P53 nuclear immunoreactivity was observed in four cases. TP53 gene sequencing was successfully performed in six cases and revealed the same mutation in both IM and ITAC in two cases (c.832C > T and c.215G > C), while another ITAC showed a mutation that was not present in the adjacent IM (c.536A > G). In conclusion, our study suggests a possible clonal relationship between areas of sinonasal IM and ITAC, indicating that IM may represent a precursor lesion of ITAC. Improving the knowledge on the morphological and molecular features of IM is a key step to identify reliable biomarkers to determine the risk of sinonasal ITAC development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25431194     DOI: 10.1007/s00428-014-1696-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  25 in total

1.  p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.

Authors:  Y S Bian; M C Osterheld; F T Bosman; J Benhattar; C Fontolliet
Journal:  Mod Pathol       Date:  2001-05       Impact factor: 7.842

2.  Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma.

Authors:  L Licitra; S Suardi; P Bossi; L D Locati; L Mariani; P Quattrone; S Lo Vullo; M Oggionni; P Olmi; G Cantù; M A Pierotti; S Pilotti
Journal:  J Clin Oncol       Date:  2004-12-15       Impact factor: 44.544

3.  Amplification of CCND1, EMS1, PIK3CA, and ERBB oncogenes in ethmoid sinus adenocarcinomas.

Authors:  Gonzalo Nazar; María V González; Juana María García; José L Llorente; Juan P Rodrigo; Carlos Suárez
Journal:  Otolaryngol Head Neck Surg       Date:  2006-07       Impact factor: 3.497

4.  The predictive value of p53, MDM-2, cyclin D1 and Ki67 in the progression from low-grade dysplasia towards carcinoma of the larynx.

Authors:  L Pignataro; P Capaccio; G Pruneri; N Carboni; R Buffa; A Neri; A Ottaviani
Journal:  J Laryngol Otol       Date:  1998-05       Impact factor: 1.469

5.  Mutations in TP53 tumor suppressor gene in wood dust-related sinonasal cancer.

Authors:  Reetta Holmila; Jette Bornholdt; Pirjo Heikkilä; Tuula Suitiala; Joëlle Févotte; Diane Cyr; Johnni Hansen; Satu-Marja Snellman; Michael Dictor; Torben Steiniche; Vivi Schlünssen; Thomas Schneider; Eero Pukkala; Kai Savolainen; Henrik Wolff; Håkan Wallin; Danièle Luce; Kirsti Husgafvel-Pursiainen
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

Review 6.  Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.

Authors:  Michelle Beilstein; Debra Silberg
Journal:  Gastroenterol Clin North Am       Date:  2002-06       Impact factor: 3.806

7.  A morphologic and immunohistochemical study of nasal mucosa in leatherworkers.

Authors:  Annarita Palomba; Tonina Enza Iaia; Mauro Biancalani; Stefano Conti; Giuseppe Battista; Bruno Papaleo; Alessandro Franchi
Journal:  Am J Rhinol       Date:  2008 Jul-Aug

8.  Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice.

Authors:  Hiroyuki Mutoh; Yoji Hakamata; Kiichi Sato; Akashi Eda; Ichiro Yanaka; Sayaka Honda; Hiroyuki Osawa; Yoshinari Kaneko; Kentaro Sugano
Journal:  Biochem Biophys Res Commun       Date:  2002-06-07       Impact factor: 3.575

Review 9.  Premalignant conditions of gastric cancer.

Authors:  Kentaro Sugano
Journal:  J Gastroenterol Hepatol       Date:  2013-06       Impact factor: 4.029

10.  Benign lesions in mucosa adjacent to intestinal-type sinonasal adenocarcinoma.

Authors:  Blanca Vivanco; José Luis Llorente; Jhudit Perez-Escuredo; César Alvarez Marcos; Manuel Florentino Fresno; Mario A Hermsen
Journal:  Patholog Res Int       Date:  2011-04-20
View more
  4 in total

1.  Colonic-type Adenocarcinoma of the Tongue and Oral Cavity (CATOC).

Authors:  Abbas Agaimy
Journal:  Head Neck Pathol       Date:  2017-08-04

Review 2.  Development of head and neck pathology in Europe.

Authors:  Henrik Hellquist; Abbas Agaimy; Göran Stenman; Alessandro Franchi; Alfons Nadal; Alena Skalova; Ilmo Leivo; Nina Zidar; Roderick H W Simpson; Pieter J Slootweg; Juan C Hernandez-Prera; Alfio Ferlito
Journal:  Virchows Arch       Date:  2022-01-14       Impact factor: 4.064

3.  Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma.

Authors:  Sannia Sjöstedt; Ane Yde Schmidt; Filipe Garrett Vieira; Gro Linno Willemoe; Tina Klitmøller Agander; Caroline Olsen; Finn Cilius Nielsen; Christian von Buchwald
Journal:  J Cancer Res Clin Oncol       Date:  2020-10-13       Impact factor: 4.553

4.  Variance-Preserving Estimation of Intensity Values Obtained From Omics Experiments.

Authors:  Adèle H Ribeiro; Julia Maria Pavan Soler; Roberto Hirata
Journal:  Front Genet       Date:  2019-09-20       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.